Pioglitazone Reverses Alcohol-Induced Alveolar Macrophage Phagocytic Dysfunction
- 15 July 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 207 (2) , 483-492
Abstract
Alcohol use disorders (AUD) increase susceptibility to respiratory infections by 2- to 4-fold in part because of impaired alveolar macrophage (AM) immune function. Alcohol causes AM oxidative stress, diminishing AM phagocytic capacity and clearance of microbes from the alveolar space. Alcohol increases AM NADPH oxidases (Noxes), primary sources of AM oxidative stress, and reduces peroxisome proliferator–activated receptor γ (PPARγ) expression, a critical regulator of AM immune function. To investigate the underlying mechanisms of these alcohol-induced AM derangements, we hypothesized that alcohol stimulates CCAAT/enhancer-binding protein β (C/EBPβ) to suppress Nox-related microRNAs (miRs), thereby enhancing AM Nox expression, oxidative stress, and phagocytic dysfunction. Furthermore, we postulated that pharmacologic PPARγ activation with pioglitazone would inhibit C/EBPβ and attenuate alcohol-induced AM dysfunction. AM isolated from human AUD subjects or otherwise healthy control subjects were examined. Compared with control AM, alcohol activated AM C/EBPβ, decreased Nox1-related miR-1264 and Nox2-related miR-107, and increased Nox1, Nox2, and Nox4 expression and activity. These alcohol-induced AM derangements were abrogated by inhibition of C/EBPβ, overexpression of miR-1264 or miR-107, or pioglitazone treatment. These findings define novel molecular mechanisms of alcohol-induced AM dysfunction mediated by C/EBPβ and Nox-related miRs that are amenable to therapeutic targeting with PPARγ ligands. These results demonstrate that PPARγ ligands provide a novel and rapidly translatable strategy to mitigate susceptibility to respiratory infections and related morbidity in individuals with AUD.Keywords
Funding Information
- HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (K99AA021803)
- HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (R00AA021803)
- HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (R01AA026086)
- U.S. Department of Veterans Affairs (1IK2CX000643)
- HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (R01AA012197)
- HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (2P50AA013757)
- U.S. Department of Veterans Affairs (1I01BX004263)
This publication has 23 references indexed in Scilit:
- The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet Psychiatry, 2018
- Alcohol and lung injury and immunityAlcohol, 2016
- Regulation of claudin/zonula occludens-1 complexes by hetero-claudin interactionsNature Communications, 2016
- Inhibition of protein phosphatase 1 reverses alcohol-induced ciliary dysfunctionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- Ethanol Induces Oxidative Stress in Alveolar Macrophages via Upregulation of NADPH OxidasesThe Journal of Immunology, 2012
- PPARγ Ligands Regulate NADPH Oxidase, eNOS, and Barrier Function in the Lung Following Chronic Alcohol IngestionAlcohol, Clinical and Experimental Research, 2011
- Alcohol Use Disorders Increase the Risk for Mechanical Ventilation in Medical PatientsAlcohol, Clinical and Experimental Research, 2007
- Glutathione availability modulates alveolar macrophage function in the chronic ethanol-fed ratAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Alcohol Use Disorder and Illicit Drug Use in Admissions to General Hospitals in the United StatesThe American Journal on Addictions, 2005
- Intercurrent complications in chronic alcoholic men admitted to the intensive care unit following traumaIntensive Care Medicine, 1996